Applying drug-like endpoints to omega-3s reviews bound to end in failure, experts say
Reaction continues to roll in on the recent Cochrane review that found little evidence supporting the cardiovascular benefits of omega-3s. Experts questioned the underlying assumptions in how the review was put together.